-
Insights on Progress Toward Patient-Centered HTA Through Evaluation of PRO Integration, Value Disconnects, and Policy Change in the EU5
Sep 9, 2025, 16:22 PM -
Which Country Is Currently Reporting the Lowest Global Prices for Semaglutide, and Why?
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of FreeStyle Libre Systems vs. Self-Monitoring of Blood Glucose in People With Type 2 Diabetes on Basal Insulin: An Israeli Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Quality of Life in Patients With Severe Hemophilia A With Inhibitors Treated With Emicizumab in Mexico
Sep 9, 2025, 16:22 PM -
Economic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Treatments for Children With Newly Diagnosed Medulloblastoma: A Systematic Review Of Randomized Controlled Trials
Sep 9, 2025, 16:22 PM -
Modeling Treatment-Free Remission Outcomes for Asciminib in Newly Diagnosed Chronic Myeloid Leukemia: Assumptions, Methodology, and Projections
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Accounting for the Additional Uncertainty Following Rank-Preserving Structural Failure Time Model (RPSFTM) Crossover Adjustment in Survival Analysis: A Sage Approach
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Impacts of Living With Primary Lateral Sclerosis (PLS): The Development of a Conceptual Model
Sep 9, 2025, 16:22 PM -
Identifying Factors Associated With Involvement in Healthcare Decisions in Wales
Sep 9, 2025, 16:22 PM -
Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals
Sep 9, 2025, 16:22 PM -
Incidence and Treatment of Squamous-Cell Anal Cancer (SCAC) in Germany: A Retrospective Study in German Statutory Health Insurance (SHI) Claims Data
Sep 9, 2025, 16:22 PM -
The Acceptability of Wearables in Remote Monitoring According to Health Technology Assessment HTA Bodies
Sep 9, 2025, 16:22 PM -
Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective
Sep 9, 2025, 16:22 PM -
Integrating Stakeholder Willingness-to-Pay Using the Van Westendorp Price Sensitivity Meter Into Cost-Effectiveness Analysis: A Mixed-Methods Pricing Framework
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in Spain
Sep 9, 2025, 16:22 PM -
Healthcare Costs in People With Type 2 Diabetes Remaining on or Escalating From Basal-Supported Oral Therapy: A 5-Year German Statutory Health Insurance Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons
Sep 9, 2025, 16:22 PM